CuPure Biotechnology
Wuxi Shi
About CuPure Biotechnology
CuiPure Biotechnology is a developer of purification processes and materials for cell gene therapy, overcoming technical difficulties in molds, fluid mechanics, material synthesis, and bioengineering. They aim to improve resolution, binding capacity, processing speed, and filler costs for large-scale industrial purification.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Funding stage: Seed
- Last round: Seed (May 2024)
Industries & Categories
Biopharma, Biotechnology, Life Science
Canonical: https://fsome.com/organization/cupure-biotechnology-2898900 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.